Literature DB >> 7913684

Bile canalicular cationic dye secretion as a model for P-glycoprotein mediated transport.

T Thalhammer1, V Stapf, L Gajdzik, J Graf.   

Abstract

This study explores properties of P-glycoprotein dependent membrane transport in rat liver with the use of acridine orange as the substrate. We studied the biliary secretion of the dye, its binding to canalicular membrane P-glycoprotein, and effects of the inhibitor cyclosporin A: acridine orange is excreted into bile together with less hydrophobic and glucuronidated metabolites. Cyclosporin A inhibited both the secretion of acridine orange and of its metabolites. In TR- animals, a rat strain that is deficient of the canalicular multi-specific organic anion transport system, non-metabolized acridine orange is the predominant species in bile and its secretion is also inhibited by cyclosporin A. Binding of acridine orange to liver P-glycoprotein was analyzed by photoaffinity labeling with azidopine, a substrate of P-glycoprotein dependent transport in multi-drug resistant tumor cells. Labeling of the immunoprecipitated P-glycoprotein was inhibited by acridine orange, verapamil, and by cyclosporin A. The results show that biliary secretion of acridine orange is highly analogous to P-glycoprotein mediated membrane drug transport in tumor cells that exhibit multi-drug resistance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913684     DOI: 10.1016/0926-6917(94)90065-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury.

Authors:  Sabrina Fan; Ching-Feng Weng
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

2.  Inward transport of [3H]-1-methyl-4-phenylpyridinium in rat isolated hepatocytes: putative involvement of a P-glycoprotein transporter.

Authors:  F Martel; M J Martins; C Hipólito-Reis; I Azevedo
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

3.  Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action?

Authors:  G Fricker; A Fahr
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.